Antitumor immunity mediated by CD8+ CTLs is the cornerstone of immune-mediated tumor elimination and the determinant of ICB effectiveness.3 Our study provides direct evidence that KDM4C is involved in regulating CD8+ T cell infiltration and activity, which was the basis for combining SD70 with RT and immunotherapy. Here, CD8A is linked to neoplasm.